UCSF 40th Annual Advances in Heart Disease

Frontiers in Cardiology: Artificial Intelligence and the Heart, Updates in Pulmonary Hypertension and Peripheral Vascular Disease

1. Artificial Intelligence and Cardiology Debate: Sonographer vs. AI – David Ouyang, MD

2. Myocarditis: Where Are We in 2023? – Bettina Heidecker, MD

3. Genetics, Artificial Intelligence and the Heart – James Pirruccello, MD

4. Pulmonary Hypertension – What is New in 2023 – Marc Simon, MD

5. Peripheral Vascular Disease Updates in 2023 – Eric Secemsky, MD

6. Elliot Rapaport Keynote Lecture: Earning Trust: The Heart of the Matter – Julie Gerberding, MD

New Approaches to Improving Outcomes in Heart Failure, Valve Disease, Pulmonary Embolism and Cardiac Arrest

1. Neuroprotection Strategies After Cardiac Arrest – Claude Hemphill, MD

2. Improving Outcomes in Acute Pulmonary Embolism – Antonio Gomez, MD

3. Interventional Approaches to Heart Failure – Lucas Zier, MD, MS

4. Modern Role of the Ross Procedure in the Treatment of Aortic Valve Disease – Marko Boskovski, MD, MHS, MPH

5. The Current State and Future Direction of Critical Care Cardiology – Chris Barnett, MD and Connor O’Brien, MD

Advances and Controversies in Electrophysiology

1. Debate: Older Patients with High CHADS-VASC and Bleeding Risk Should Have Left Atrial Appendage Closed – Tommy Dewland, MD (pro) and Adam Lee, MD (con)

2. Pacing for Heart Failure with Preserved Ejection Fraction – Ram Venkateswaran, MD

3. Debate: Treatment for Symptomatic Atrial Fibrillation First-line Ablation vs. Pharmacologic Therapy – Ed Gerstenfeld, MD and Joshua Moss, MD

4. New Technologies in Pacing for Central Sleep Apnea and Heart Failure – Byron Lee, MD

5. The Effect of Alcohol, Caffeine and Tobacco on Atrial Fibrillation – Are Any Vices OK? – Gregory Marcus, MD, MAS

Managing Heart Failure

1. Polypharmacy and Medication Costs for Guideline Directed Medical Therapy for Patients with Heart Failure with Reduced Ejection Fraction – Rose Pavlakos, PharmD

2. Remote Monitoring of Patients with Heart Failure – Liviu Klein, MD, MS

3. Right Ventricular Heart Failure – Brian Houston, MD

4. Review of Guideline for and Management of Heart Failure – Jonathan Davis, MD, MPHS

5. Approach to Multivessel Coronary Artery Disease in Patients with Reduced Ejection Fraction – Amy Fiedler, MD and Krishan Soni, MD, MBA

Managing Cardiovascular Risk

1. Clonal Hematopoiesis of Indeterminate Potential (CHIP): A Novel Cardiovascular Risk Factor – Peter Libby, MD

2. Lipid Management Beyond Statins: What, Why, and Who? – Christie Ballantyne, MD

3. Lp(a): Why is It Important? – Michelle O’Donoghue, MD, MPH

4. Weight Loss and Cardiovascular Risk: Current Concepts – Sarah Kim, MD

5. Making Sense of Popular Diets: Alignment with AHA 2021 Dietary Guidance – Christopher Gardner, PhD